| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 08/29/2006 | US7098212 Piperazine derivatives |
| 08/29/2006 | US7098202 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/24/2006 | WO2006089024A1 Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans |
| 08/24/2006 | WO2006088963A1 Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans |
| 08/24/2006 | WO2006088716A1 Substituted tetralins as selective estrogen receptor-beta agonists |
| 08/24/2006 | WO2006088694A1 SUBSTITUTED THIENYL AND FURYL ACYLGUANIDINES AS β-SECRETASE MODULATORS |
| 08/24/2006 | WO2006088193A1 Anti-tumor agent |
| 08/24/2006 | WO2005004810A3 Arylsulfonamide derivatives |
| 08/24/2006 | US20060189816 Product |
| 08/24/2006 | US20060189810 Novel sulfonamide inhibitors of aspartyl protease |
| 08/24/2006 | US20060189684 3-Phenylfuran-2-one derivatives as cox-2 inhibitor |
| 08/24/2006 | US20060189674 Deacetylase inhibitors |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189611 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/24/2006 | US20060189578 Method for the synthesis of compounds of formula I and their uses thereof |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/24/2006 | DE102005005875A1 3-Amino-2-aminmethyl-phenol-Derivate und diese Verbindungen enthaltende Färbemittel 3-amino-2-amine, methyl-phenol derivatives and coloring agents containing these compounds |
| 08/24/2006 | CA2599046A1 Antitumor agent |
| 08/24/2006 | CA2597982A1 Boron-containing small molecules |
| 08/23/2006 | EP1692127A2 Triphenylethylene compounds as selective estrogen receptor modulators |
| 08/23/2006 | EP1692124A1 Biaryl sulfonamides as mmp inhibitors |
| 08/23/2006 | EP1692123A1 Phenyl-furan compounds as vitamin d receptor modulators |
| 08/23/2006 | EP1692098A1 Alpha-ketoamide derivative, and production method and use thereof |
| 08/23/2006 | EP1692093A1 Biphenyl derivatives useful as ligands that activate the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 08/23/2006 | EP1438349B1 Triarylamine containing monomers for optoelectronic devices |
| 08/23/2006 | EP1235820B1 Ether-capped poly(oxyalkylated) alcohol surfactants |
| 08/23/2006 | EP1190079B1 Control of gene expression in eukaryotic cells |
| 08/23/2006 | EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same |
| 08/23/2006 | CN1271074C Ramification of chirality multi ring quinoline tetroxide, preparation method and usage |
| 08/23/2006 | CN1271072C Process for the preparation of 14-hydroxymorphine derivatives |
| 08/23/2006 | CN1271066C Aromatic dicarboxylic acid derivatives |
| 08/23/2006 | CN1271063C Di (5-formylfurfuryl) ether derivatives, preparations thereof and their uses in medicines |
| 08/23/2006 | CN1271062C Method for preparing ramification of monoterpenes |
| 08/22/2006 | US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 08/22/2006 | US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 08/22/2006 | US7094807 Viricides; hepatitis virus |
| 08/22/2006 | US7094806 Bactericides, bacteriostats |
| 08/22/2006 | US7094805 Total synthesis of merrilactone A |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/17/2006 | WO2006086374A2 3-amino-2-aminomethylphenol derivatives and colorants comprising these compounds |
| 08/17/2006 | WO2006085510A1 Remedy for irritable bowel syndrome |
| 08/17/2006 | WO2006085113A2 2-substituted 5-membered heteroaryl carboxylates as hm74a receptor agonists |
| 08/17/2006 | WO2006085049A2 Michael addition product and schiff's base aromachemicals |
| 08/17/2006 | WO2006085048A2 Pro-fragrance and pro-flavorant compositions |
| 08/17/2006 | WO2006084338A1 Novel tubulin polymerisation inhibitors |
| 08/17/2006 | WO2006037982A3 Modulators of crth2 receptor activity for the treatment of prostaglandin d2 mediated diseases |
| 08/17/2006 | WO2006028977A3 Chiral spiro compounds and their use in asymmetric catalytic reactions |
| 08/17/2006 | WO2006025920A3 Modulators of central nervous system neurotransmitters |
| 08/17/2006 | US20060183925 Process for the preparation of a cyano-isobenzofuran |
| 08/17/2006 | US20060183791 Substituted p-diaminobenzene derivatives |
| 08/17/2006 | US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 08/17/2006 | CA2597447A1 Novel tubulin polymerisation inhibitors |
| 08/17/2006 | CA2597240A1 Michael addition product and schiff's base aromachemicals |
| 08/17/2006 | CA2597237A1 Pro-fragrance and pro-flavorant compositions |
| 08/17/2006 | CA2592320A1 Methods and compositions for treating amyloid-related diseases |
| 08/16/2006 | EP1690883A1 Pellicle and novel fluorinated polymer |
| 08/16/2006 | EP1690854A1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 08/16/2006 | EP1690853A1 W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/16/2006 | EP1689732A2 Cationic substituted benzofurans as antimicrobial agents |
| 08/16/2006 | EP1689731A1 2-phenyl-benzofuran derivatives, method for the production thereof and their use |
| 08/16/2006 | EP1689730A1 Gsk-3 inhibitors isolated from marine organisms |
| 08/16/2006 | EP1689729A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 08/16/2006 | EP1689716A1 Biaryl sulfonamides and methods for using same |
| 08/16/2006 | EP1689706A2 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders |
| 08/16/2006 | EP1689702A1 Organic compounds |
| 08/16/2006 | EP1689494A1 Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer |
| 08/16/2006 | EP1689380A2 Method for treating adamts-5-associated disease |
| 08/16/2006 | EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 08/16/2006 | EP1318991B1 Benzoic acid derivatives and uses thereof |
| 08/16/2006 | EP0888326B1 Novel ortho-naphthoquinone derivatives, novel synthesis therefor, and their use in the inhibition of neoplastic cell growth |
| 08/16/2006 | CN1819999A Method for obtaining oligomers of polytetrahydrofurane or tetrahydrofurane copolymers |
| 08/16/2006 | CN1817872A Process for the preparation of substituted octanoyl amides |
| 08/16/2006 | CN1817864A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 08/16/2006 | CN1269809C Process for ascorbic acids using alkaline earth silicate catalysts |
| 08/16/2006 | CN1269805C 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders |
| 08/16/2006 | CN1269800C Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators |
| 08/16/2006 | CN1269780C Method for production of tetrahydrofuran |
| 08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
| 08/15/2006 | US7091371 Treating an animal for parasites |
| 08/15/2006 | US7091247 urotensin antagonists; vasoactive agents |
| 08/15/2006 | US7091245 Peroxisome proliferator activator; antidiabetic agents; insulin resistance; |
| 08/15/2006 | US7091240 Destroying tumor cell vasculation; antitumor agents; anticancer agents |
| 08/15/2006 | US7091237 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 08/15/2006 | US7091219 Administering an effective amount of bis-sulfonamide hydroxyethyl-amino derivative to a HIV patient to prevent the viral replication |
| 08/15/2006 | CA2258048C Process of preparing phenyl heterocycles useful as cox-2 inhibitors |
| 08/15/2006 | CA2238376C Benzofuran carboxamides and sulphonamides |
| 08/10/2006 | WO2006084056A2 Compounds and methods for modulating communication and virulence in quorum sensing bacteria |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006083266A1 Inhibitors of bacterial type iii protein secretion systems |
| 08/10/2006 | WO2006082165A1 Method for controlling hydrogenation |
| 08/10/2006 | WO2006082010A1 Inhibitors of diacylglycerol acyltransferase (dgat) |
| 08/10/2006 | WO2006081659A1 Meroterpenoid inhibitors of phosphoinositide 3 kinase (pi3k) |
| 08/10/2006 | US20060178429 2-Phenyl-3-hydrogenated furanyl, pyranyl, thiophenyl or thiopyranyl-N-heteroaromatic propionamides, e.g., 2-(3,4-Dichloro-phenyl)-3-(tetrahydro-pyran-2-yl)-N-thiazol-2-yl-propionamide; compounds increase insulin secretion in the treatment of type II diabetes. |
| 08/10/2006 | US20060178418 For therapy of asthma, bronchial asthma, chronic obstructive pulmonary disease, allergic rhinitis, eosinophilic granuloma, nephritis, rheumatoid arthritis, cystic fibrosis, chronic bronchitis, multiple sclerosis, Crohns disease, psoraisis, uticaria, adult vernal conjunctivitis, |
| 08/10/2006 | US20060178414 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma; e.g., 2-Methoxynaphthalene-1-carboxylic acid benzyl-indan-2-yl-amide |
| 08/10/2006 | US20060178366 Compounds for the treatment of inflammatory disorders |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | DE102005005973A1 Verfahren zur Regenerierung von inertem Trägermaterial deaktivierter Oxidationskatalysatoren Process for the regeneration of inert carrier material deactivated oxidation catalysts |
| 08/10/2006 | CA2596639A1 Inhibitors of diacylglycerol acyltransferase (dgat) |